Skip to main content
SpringerLink
Log in

Magnetisches Drug-Targeting

Neue Wege zur lokalen Wirkstoffanreicherung in Kopf- und Halskarzinomen

  • Im Fokus
  • Published:
HNO Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Literatur

  1. Alexiou C, Arnold W, Klein RJ et al. (2000) Locoregional cancer treatment with magnetic drug targeting. Cancer Res 60: 6641–6648

    CAS  PubMed  Google Scholar 

  2. Alexiou C, Jurgons R, Schmid RJ et al. (2003) Magnetic drug targeting — biodistribution of the magnetic carrier and the chemotherapeutic agent mitoxantrone after locoregional cancer treatment. J Drug Target 11: 139–149

    Article  CAS  PubMed  Google Scholar 

  3. Alexiou C, Jurgons R, Schmid RJ, Erhardt W, Parak F, Bergemann C, Iro H (2004) Magnetic Drug Targeting — a new approach in locoregional tumor therapy with chemotherapeutic agents. Experimental animal studies. HNO (in press)

  4. Arbab AS, Jordan EK, Wilson LB, Yocum GT, Lewis BK, Frank JA (2004) In vivo trafficking and targeted delivery of magnetically labeled stem cells. Hum Gene Ther 15: 351–360

    Article  CAS  PubMed  Google Scholar 

  5. Bernier J, Domenge C, Ozsahin M et al. (2004) Postoperative irradiation with or without concomitant chemotherapy for locally advanced head and neck cancer. N Engl J Med 350: 1945–1952

    Article  CAS  PubMed  Google Scholar 

  6. Forastiere AA, Goepfert H, Maor M et al. (2003) Concurrent chemotherapy and radiotherapy for organ preservation in advanced laryngeal cancer. N Engl J Med 349: 2091–2098

    Article  CAS  PubMed  Google Scholar 

  7. Ito A, Kuga Y, Honda H, Kikkawa H, Horiuchi A, Watanabe Y, Kobayashi T (2004) Magnetite nanoparticle-loaded anti-HER2 immunoliposomes for combination of antibody therapy with hyperthermia. Cancer Lett 212: 167–175

    Article  CAS  PubMed  Google Scholar 

  8. Kharkevich DA, Alyautdin RN, Filippov VI (1989) Employment of magnet-susceptible microparticles for the targeting of drugs. J Pharm Pharmacol 41: 286–288

    CAS  PubMed  Google Scholar 

  9. Kubo T, Sugita T, Shimose S, Nitta Y, Ikuta Y, Murakami T (2000) Targeted delivery of anticancer drugs with intravenously administered magnetic liposomes in osteosarcoma-bearing hamsters. Int J Oncol 17: 309–315

    CAS  PubMed  Google Scholar 

  10. Kubo T, Sugita T, Shimose S, Nitta Y, Ikuta Y, Murakami T (2001) Targeted systemic chemotherapy using magnetic liposomes with incorporated adriamycin for osteosarcoma in hamsters. Int J Oncol 18: 121–125

    CAS  PubMed  Google Scholar 

  11. Leakakos T, Ji C, Lawson G, Peterson C, Goodwin S (2003) Intravesical administration of doxorubicin to swine bladder using magnetically targeted carriers. Cancer Chemother Pharmacol 51: 445–450

    CAS  PubMed  Google Scholar 

  12. Lubbe AS, Bergemann C, Huhnt W, Fricke T, Riess H, Brock JW, Huhn D (1996) Preclinical experiences with magnetic drug targeting: tolerance and efficacy. Cancer Res 56: 4694–4701

    CAS  PubMed  Google Scholar 

  13. Lubbe AS, Bergemann C, Riess H et al. (1996) Clinical experiences with magnetic drug targeting: a phase I study with 4’-epidoxorubicin in 14 patients with advanced solid tumors. Cancer Res 56: 4686–4693

    CAS  PubMed  Google Scholar 

  14. Nobuto H, Sugita T, Kubo T, Shimose S, Yasunaga Y, Murakami T, Ochi M (2004) Evaluation of systemic chemotherapy with magnetic liposomal doxorubicin and a dipole external electromagnet. Int J Cancer 109: 627–635

    Article  CAS  PubMed  Google Scholar 

  15. Widder KJ, Senyei AE, Ranney DF (1980) In vitro release of biologically active adriamycin by magnetically responsive albumin microspheres. Cancer Res 40: 3512–3517

    CAS  PubMed  Google Scholar 

  16. Widder KJ, Morris RM, Poore G, Howard DP Jr, Senyei AE (1981) Tumor remission in Yoshida sarcoma-bearing rats by selective targeting of magnetic albumin microspheres containing doxorubicin. Proc Natl Acad Sci U S A 78: 579–581

    Google Scholar 

Download references

Interessenkonflikt:

Der korrespondierende Autor versichert, dass keine Verbindungen mit einer Firma, deren Produkt in dem Artikel genannt ist, oder einer Firma, die ein Konkurrenzprodukt vertreibt, bestehen.

Author information

Authors and Affiliations

  1. HNO-Kliniken, Universitäten Heidelberg und Tübingen

    C. Simon

  2. HNO-Klinik, Eberhard-Karls-Universität, Elfriede-Aulhorn-Straße 5, 72076, Tübingen

    C. Simon

Authors
  1. C. Simon
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to C. Simon.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Simon, C. Magnetisches Drug-Targeting. HNO 53, 600–601 (2005). https://doi.org/10.1007/s00106-005-1278-2

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00106-005-1278-2

Search

Navigation